mHealth Solutions Market to Progress at a Healthy CAGR in Coming Years

 

The growing adoption of smartphones, increasing penetration of 3G/4G networks, rising focus on cost containment in healthcare delivery, and the increasing demand for home healthcare services are some of the key factors driving the growth of this market.

The report mHealth Solutions Market is projected to reach USD 213.6 billion by 2025 from USD 50.8 billion in 2020, at a CAGR of 33.3 % during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1232

Market Segmentation:-

Based on product and service, the Mobile Health Apps Market segment accounted for the largest share of the mHealth solutions market in 2019. The large share of this segment can be attributed to the high and growing penetration of smartphones and healthcare apps and the rising incidence of chronic and lifestyle-related diseases across the globe (coupled with the effective utilization of apps in chronic disease management).

Key Market Drivers :-
            1 Increasing Penetration of Smartphones, Tablets, and Other Mobile Platforms
            2 Increasing Utilization of Connected Devices and mHealth Apps for the Management of        Chronic Diseases
            3 Cost Containment in Healthcare Delivery
            4 Robust Penetration of 3G and 4G Networks for Uninterrupted Healthcare Services
            5 Rising Focus on Patient-Centric Healthcare Delivery
            6 Increasing Demand for Home Healthcare Services

Regional Analysis:-

Based on region, the Medical Apps Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest market share in 2019.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1232

Top Key Players:-

The prominent players in the Mobile Health Apps Market are Medtronic plc (Ireland), Apple, Inc. (US), AirStrip Technologies (US), AliveCor, Inc. (US), Nike, Inc. (US), Koninklijke Philips N.V. (Netherlands), Johnson & Johnson (US), Omron Corporation (Japan), BioTelemetry, Inc. (US), athenahealth, Inc. (US), AgaMatrix, Inc. (US), Withings S.A. (France), and iHealth Labs, Inc. (US).

New report examines the Pharmaceutical Packaging Equipment Market worth $10.4 billion by 2025

The growth of the global pharmaceutical packaging equipment industry is driven by the rapidly growing generic and biopharmaceutical markets, growth in OTC drug sales, rising need for flexible and integrated packaging equipment, increased offshore manufacturing in the pharmaceuticals market, and the introduction of regulatory standards on packaging and stringent norms against counterfeiting.

The global Pharmaceutical Packaging Equipment Market size is projected to reach USD 10.4 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 7.4% from 2020 to 2025.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19845828

Market Segmentation:-

On the basis of product, the pharmaceutical packaging equipment market is segmented into primary packaging equipment, secondary packaging equipment, and labeling and serialization equipment. In 2019, the primary packaging equipment segment accounted for the largest share of the pharmaceutical packaging equipment market. The main function of primary packaging is to restrict climatic, chemical, or biological hazards that cause deterioration. The rising need for the aseptic filling and sealing of drug molecules into sterile containers and the increasing demand for parenteral vials and prefillable syringes are supporting the growth of this segment.

Based on type, the Pharmaceutical Packaging Equipment Industry is segmented into liquid, solid, semi-solid, and other packaging equipment. In 2019, the liquid packaging equipment segment accounted for the largest share of the pharmaceutical packaging equipment market, followed by solid and semi-solid packaging equipment segments.

Key Market Drivers: -
            1 High growth in the generics and biopharmaceuticals markets
            2 Growing need for flexible and integrated packaging equipment
            3 Increase in offshore pharmaceutical manufacturing

Regional Analysis:-

Geographically, the Pharmaceutical Packaging Equipment Industry is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Growth in the European market is driven majorly by the high pharmaceutical production, increasing demand for flexible packaging equipment by major pharmaceutical manufacturers, and the rising focus on product diversification by companies, driving the demand for innovative packaging equipment.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=19845828

Top Key Players:-

The prominent players in this market are Syntegon Technology (Germany), IMA S.p.A. (Italy), Körber AG (Germany), Uhlmann Group (Germany), OPTIMA Packaging Group (Germany), Romaco Holding (Germany), Marchesini Group (Italy), ACG Worldwide (India), Coesia S.p.A. (Italy) and MULTIVAC Group (Germany).

Pharmaceutical Membrane Filtration Market : Trends and Developments

The growth of this market is primarily driven by the growth of the pharmaceutical and biopharmaceutical industry, increasing demand for single-use technologies, and the advancements in nanofiltration techniques.

The global Pharmaceutical Membrane Filtration Market  is valued at an estimated USD 5.1 billion in 2019 and is projected to reach USD 8.6 billion by 2024, growing at a CAGR of 11.0% during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031

Market Segmentation:-

On the basis of product, the pharmaceutical membrane filtration market is segmented into filters, systems, and accessories. Filters formed the largest product segment in this market owing to the high and growing use of different types of membrane filters for various filtration applications in the biopharmaceutical manufacturing industry.

On the basis of application, the Micro Filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. Final product processing was the largest application segment in the pharmaceutical membrane filtration market in 2018.

Regional Analysis:-

The global pharmaceutical membrane filtration market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America was the largest market for Micro Filtration market, followed by Europe.

Recent Developments:-

1. In 2018, Pall Corporation opened a center of excellence for training on sterilization techniques, filtration, and cell culture platforms.
2. In 2018, GE Healthcare and the Swedish Government opened an innovation center—Testa Center—in Sweden to support the commercialization of advanced biopharmaceuticals.
3. In 2016, Sartorius Stedim Biotech opened its production and R&D facility in England.

Speak to Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=255408031

Key Market Players:-

The major companies operating in the pharmaceutical membrane filtration market include Merck Millipore (Germany), Danaher (US) and Sartorius Stedim Biotech (France).

Hemodialysis & Peritoneal Dialysis Market to Witness Steady Growth in the Near Future

Growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension, shortage of organ donors and risks associated with transplant, technological advancements and new product launches, and rising R&D expenditure for developing new dialysis products.

The report Hemodialysis & Peritoneal Dialysis Market  is projected to reach USD 99.2 billion by 2024 from USD 74.2 billion in 2019, at a CAGR of 6.0%.

Download PDF Brochure:-  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279

Market Segmentation:-

The global hemodialysis market is broadly categorized into two segments, namely, hemodialysis products and hemodialysis services market. The hemodialysis products market include machines (center-use & home-use machines) & consumables (dialyzers, access products, bloodlines, dialysates, and other consumables). The hemodialysis services (including in-center & home- hemodialysis services) segment is expected to account for the largest share of the hemodialysis market.

The peritoneal dialysis market, by modality, includes continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The APD segment is expected to grow at the highest CAGR owing to its several advantages over CAPD, such as daytime freedom for patients, fewer connections and disconnections (and hence a lower probability of peritonitis), and improved quality of life. Being automated, APD is also the preferred dialysis treatment for the elderly and children.

Key Market Drivers: -
            1 Increasing Number of ESRD Patients
            2 Growing Prevalence of Diabetes and Hypertension
            3 Shortage of Organ Donors and Risks Associated With Transplant
            4 Technological Advancements and New Product Launches
            5 Rising R&D Expenditure for Developing New Dialysis Products

Regional Analysis:-

Based on region, the hemodialysis and peritoneal dialysis market has been segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the hemodialysis and peritoneal dialysis market in 2019.

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1279

Key Market Players:-

The major players operating in the global hemodialysis and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (US), Baxter International, Inc. (US), and B. Braun Melsungen AG (Germany).

Report explores the Infusion Pump Market worth $18.9 billion by 2025

 

The rising demand for ambulatory infusion pumps in home care settings, increasing incidence of chronic diseases along with the rapid growth of the geriatric population, and growing number of surgical procedures performed are the major factors driving the growth of this market.

The global Infusion Pump Market is projected to reach USD 18.9 billion by 2025 from USD 13.5 billion in 2020, at a CAGR of 7.0% during the forecast period.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506 

Market Segmentation:-

Based on products, the Infusion Pumps Accessories Market is segmented into accessories & consumables and devices. The accessories & consumables segment is expected to grow at the highest CAGR during the forecast period.

Based on product, the infusion pumps market is segmented into dedicated accessories & consumables and non-dedicated accessories & consumables. The dedicated accessories & consumables segment is expected to grow at the highest CAGR during the forecast period.

Based on type, the Infusion Pumps Accessories Market has been segmented into traditional infusion pumps and specialty infusion pumps market. The specialty infusion pumps segment is expected to grow at the highest CAGR during the forecast period.

Based on application, the Infusion Pumps Accessories Market is segmented into chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other applications (includes infectious diseases, autoimmune diseases, and diseases of the heart, kidney, lung, and liver).

On the basis of end user, the infusion pumps market has been segmented into hospitals, home care settings, ambulatory care settings, and academic and research institutes.

Key Market Drivers: -
            1 Rising demand for ambulatory infusion pumps in home care settings
            2 Increasing incidence of chronic diseases along with the rapid growth of the geriatric population
            3 Growing numbers of surgical procedures performed

Regional Analysis:-

North America accounted for the largest share of the infusion pumps market in 2019, followed by Europe.

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=90374506

Key market Players:-

The prominent players in this market are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), ICU Medical, Inc. (US), Medtronic plc (Ireland), Mindray Medical International Limited (China), Micrel Medical Devices SA (Greece), and Ypsomed Holding AG (Switzerland), among other key players.

 

Chromatography Instruments Market to Expand at a Healthy Growth Rate in the Coming Years

The rising popularity of hyphenated chromatography techniques, the growing importance of chromatography tests in the drug approval process, and rising food safety concerns are the major factors driving the growth of this market.

What the Market Looks Like?

The report Chromatography Instruments Market  was valued at USD 7.8 billion in 2017. This market is estimated to grow at a CAGR of 6.9% during the forecast period, expected to be worth USD 10.9 billion by 2022.

Based on type, the chromatography instruments market is segmented into systems, detectors, auto-samplers, and fraction collectors. The systems segment dominated this market in 2017 and is also estimated to grow at the highest CAGR during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1258

What Drives the Market?

The growth of the global market for Chromatography Instruments is primarily influenced by the following factors:

·         Policies and Initiatives to Reduce Environmental Pollution Levels

·         Growing Food Safety Concerns

·         Growing Importance of Chromatography Tests in the Drug Approval Process

·         Rising Popularity of Hyphenated Techniques

·         New Product Launches and Their Expanding Application Areas

 

Life science research, food & beverage testing, environmental testing, and other applications are the main segments of the market. Life science research is the largest and the fastest-growing application segment in this market majorly due to the increasing importance of chromatography tests in the drug approval process and the rising number of R&D activities in the pharmaceutical and biotechnology industries.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=1258

 

 

360quadrants Releases Quadrant on Best Human Resource Software Vendors

 Human Resource Software is a digital solution that helps handle and improve the routine human resource responsibilities and general human resource objectives of an enterprise. The software enables HR professionals to manage their time and resources efficiently in order to be more productive. The main objective of a Human Resource software is to help an organization’s HR team with automation, arranging employee data, and creating informative reports. It also helps manage activities such as time tracking, updating employee data, and managing and improving performance.

360Quadrants has analyzed the companies offering the best Human Resource Software. This analysis will help businesses select the software that best suits their requirements. The analysis has been based on critical parameters taken from the company’s product offerings and business strategies. 360Quadrants also helps businesses by providing critical insights derived from conducting a SWOT analysis. 

Human Resource Software 360quadrants Positioning 

360Quadrants studied over 175 companies that provide best Human Resource Software solutions. Amongst all, the top 10 Human Resource Software providers were shortlisted and positioned on a quadrant under the following categories: Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Leaders. 

Paylocity, ADP Vantage, Workday HCM, Kronos Workforce Ready, SAP Successfactors, and Zoho People were positioned as Visionary Leaders.

Oracle HCM Cloud was acknowledged as an Innovator.  
Cascade HR was recognized as an Emerging Company.  
Vibe HCM and iSolved were categorized as Dynamic Differentiators. 

Breast Biopsy Market to Witness Steady Growth in the Near Future

Technological advancements in the field of a breast biopsy and the rising incidence of breast cancer are the major factors driving the growth of this market. Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other significant factors driving the growth of this market.

The report Breast Biopsy Market is projected to reach USD 1,094 million by 2025 from USD 725 million in 2020, at a CAGR of 8.6% during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805

Market Segmentation:-

Based on the product, the breast biopsy market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other products. In 2019, the biopsy needles held significant share of the market. The major share of this segment is primarily attributed to the rising incidence of breast cancer and the growing breast cancer diagnosis rate in developing countries.

Based on guidance, the Breast Biopsy Devices Market is segmented into image-guided biopsy and liquid biopsy. The liquid biopsy segment is further divided into NGS-based, PCR-based, and Microarray-based biopsy. Among these, the NGS-based biopsy segment is expected to register significant growth over the forecast period.

Based on type, the Breast Biopsy Devices Market is segmented into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. In 2019, the needle breast biopsy held a major share of the breast biopsy market. Needle biopsy has replaced conventional excisional biopsy as the standard diagnostic procedure for breast cancer.

Key Market Drivers: -
            1 Growing incidence of breast cancer
            2 Increasing number of breast cancer screening programs
            3 Increasing demand for minimally invasive and non-invasive procedures
            4 Growing awareness regarding early detection of breast cancer
            5 Improved reimbursement scenario

Regional Analysis:-

The breast biopsy market is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American region accounted for the largest share of the breast biopsy market in 2019.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=189011805

Top Key Players:-

The major players operating in the breast biopsy market are Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US), QIAGEN (Netherlands), Biocept Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Menarini Silicon Biosystems, Spa (Italy), Exact Sciences Corporation (US), Illumina, Inc. (US), and Fluxion Biosciences Inc (US), among others.

In Vitro Diagnostics Market to witness major growth in coming years

Factors such as increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness on personalized medicine, increasing adoption of fully-automated instruments and automation in laboratories, and increasing adoption of point-of-care testing are driving the market growth.

The global In Vitro Diagnostics Market to grow from USD 68.12 billion in 2018 to USD 87.93 billion by 2023, at a CAGR of 5.2% during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703

Market Segmentation:-

Based on applications, the IVD market is segmented into diabetes, infectious diseases, oncology, cardiology, nephrology, autoimmune diseases, drug testing/pharmacogenomics, HIV/AIDS, and other applications (neurological tests, endocrine tests, blood analysis tests, pregnancy tests, and general clinical applications). The infectious diseases segment accounted for the largest share of the IVD applications market in 2017.

Based on technology, the In Vitro Diagnostics Industry is broadly divided into immunochemistry/immunoassay, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation & hemostasis, urinalysis, and other technologies (patient self-testing, point-of-care testing, lateral flow assays, and tissue processing). The immunochemistry/immunoassay segment is expected to dominate the market in 2018.

Based on end user, the IVD market is segmented into laboratories (large/reference laboratories, medium-sized laboratories, and small laboratories), hospitals, academic institutes, point-of-care testing, patient self-testing, and other end users. The point-of-care testing segment is expected to grow at the highest CAGR during the forecast period.

Key Market Drivers: -
            1 Rising Geriatric Population and Subsequent Growth in the Prevalence of Chronic and Infectious Diseases
            2 Increasing Adoption of Fully Automated Instruments and Automation in Laboratories
            3 Growing Awareness on Personalized Medicine
            4 Increasing Adoption of Point-Of-Care Testing

Regional Analysis:-

Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to dominate the market followed by Europe.

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=703

Top Key Players:-

The prominent players in the global in vitro diagnostics market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Agilent Technologies (US), and QIAGEN (Germany).

 

Best e-commerce platforms: An Outlook to the Future Global Opportunities

The Best e-Commerce platform is a comprehensive software tool that allows merchants to build and manage a digital storefront for their products or services. Because best e-Commerce platforms create a centralized, digital hub for product and customer data, they allow eCommerce businesses to do things like customizing product information, manage web content and layout, allow online transactions to occur, and adjust the platform according to businesses’ online needs.

The global market size of Best E-Commerce Platforms has been estimated at USD 6.5 billion in 2019 and is expected to rise at a compound annual growth rate (CAGR) of 16 per cent between 2020 and 2027. E-commerce tech simplifies complicated procedures and lets firms control their inventory, measure taxes and efficiently handle certain business-related functions. Growing people's embrace of online shopping has contributed to a need for many retailers for e-commerce apps.

Read More: - https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-e-commerce-platforms

In 2019 the cloud segment had the maximum share of the business. This is due to the growing proliferation of cloud-based technologies through various vertical lines of industry. Cloud-based delivery provides many benefits including flexible computing space, streamlined control, fast performance and redundancy. It is projected that the on-premise market would experience a CAGR of over 6.0 per cent between 2020 and 2027. On-premise installation limits the user's complete control and thus decreases the need for extra security. The delivery process allows the customer complete power over the hardware and the program upgrades.

Best E-Commerce Platforms offers hospitals, clinics, and other wellness institutes potential to simplify their buying decision of hospital devices and other supplies. The shift of manufacturing companies of medical devices to digital sites has given market players potential for advancement.

Asia Pacific is expected to see the fastest development over the projected period. This recent surge is due to measures in their respective nations carried out by the government of countries like China and India to encourage digitalisation. Due to this, there has been significant growth in internet users.

The best E-Commerce Platforms tech industry is highly decentralized and marked by strong global competition, as many market participants perform their business operations across the world. The Best E-Commerce Platforms industry has witnessed numerous strategies of inorganic expansion, such as acquisitions and mergers, alliances, and cooperation that businesses have embraced in the past years.